Felix M. WensveenUniversity of Rijeka1 paperORCID 0000-0002-1333-8882 ↗OpenAlex ↗PapersFrontiers in EndocrinologyHuman trial·28 Sepγδ T-cell interferon-γ production reflects metabolic improvement during SGLT2 inhibitor-based therapy in type 2 diabetes
Frontiers in EndocrinologyHuman trial·28 Sepγδ T-cell interferon-γ production reflects metabolic improvement during SGLT2 inhibitor-based therapy in type 2 diabetes